Skip to Main content Skip to Navigation
Journal articles

Deregulated MITF sumoylation: A route to melanoma

Abstract : Metastatic melanoma is a deadly form of skin cancer. Extraordinary breakthroughs have been recently achieved in the treatment of the disease,1 leading to objective increase in patient survival. However, early detection of potential dangerous melanocytic lesions remains the best strategy to avoid metastatic dissemination, which is still the main cause of death in melanoma patients. In 2011, our team identified a germline mutation in microphthalmia-associated transcription factor (MITFE318K ) that predisposes carriers to melanoma. Recently, we demonstrated that this mutation interfered with oncogene-induced senescence, one of the first events that should be overcome to allow melanoma development. Therefore, our works provide important clues on the early steps of melanomagenesis and as such might be useful for prevention or early therapeutic interventions in at risk-patients.
Keywords : MITF Melanoma senescence
Complete list of metadatas

Cited literature [10 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02529950
Contributor : Bertolotto-Ballotti Bertolotto-Ballotti <>
Submitted on : Tuesday, April 7, 2020 - 2:22:15 PM
Last modification on : Tuesday, May 26, 2020 - 6:50:46 PM

File

Ballotti MCO.pdf
Files produced by the author(s)

Identifiers

Collections

Citation

Robert Ballotti, Corine Bertolotto. Deregulated MITF sumoylation: A route to melanoma. Molecular & Cellular Oncology, Taylor et Francis, 2017, 4 (4), pp.e1331154. ⟨10.1080/23723556.2017.1331154⟩. ⟨inserm-02529950⟩

Share

Metrics

Record views

43

Files downloads

18